Skip to content
Life Sciences Series A Founded 2017

Cessation Therapeutics

Developer of immunotherapy based vaccines to manage addictions

📍 San Jose, United States · Neurology

Funding snapshot

Last roundSeries A
Amount$1M
Date29 March 2024

About

Developer of immunotherapy based vaccines to manage addictions. It offer drug conjugate vaccine molecules to overcome addictions such as overcome the opioid, heroin, morphine, fentanyl, alcohol and nicotine addiction use disorders. It contains drug-like “hapten” linked to an immunogenic protein and formulated with immune-stimulating substances directing the immune system to produce antibodies and induce immunity to drugs of abuse.

Latest news

No articles yet.

Raising like Cessation Therapeutics?

Analyze your pitch deck before your next raise.

Analyze My Deck →